ERBB2 and breast carcinoma: Closely parallel to our observations of the negative regulation of BST2 in breast cancer, AP2 is involved in the repression of promoter sequences of the oncogene, ERBB2[26], evident as an inverse correlation between AP2 and ERBB2 immunolocalization in archival tumor specimens [27].